5-Bromo-2,4-dichlorophenol, 95.0%, 10g

Propionic anhydride, min 98.5%, for synthesis, 2.5L, glass packaging

N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride, 95.0%, 250mg

(2,3-Difluorophenyl)(4-methylpiperazin-1-yl)methanone, 98%, 5g

Ethyl 6-chloro-1H-pyrrolo[3,2-b]pyridine-5-carboxylate, 98%, 100mg

1-(1-Methyl-1H-benzimidazol-2-yl)ethanone, 95.0%, 1g

4'-Methoxyflavone>98.0%(GC)1g

2-Hydroxy-3-methoxybenzamide, 98%, 250mg

N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, 95+%, 5mg

(Z)-Methyl 3-(((4-(N-methyl-2-(piperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate ( Nintedanib Impurity), 97%, 50mg

2-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 250mg

2-(4-t-Butylbenzoyl)oxazole, 97.0%, 1g

1-Hydroxybutan-2-one, 95.0%, 5g